Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways
- PMID: 8642312
- PMCID: PMC2192566
- DOI: 10.1084/jem.183.5.2017
Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways
Abstract
T helper type 1 cells (Th1) become anergic when stimulated through the antigen receptor in the absence of costimulation. They do not produce IL-2 or proliferate in response to subsequent stimulation. Previous studies have indicated that anergic T cells are defective in the trnsactivational activity of the transcription factor, AP-1, which is required for optimal IL-2 transcription. Using two murine Th1 cell clones, we demonstrate that anergic Th1 cells have defects in both jun NH2-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) activities. These kinases have been shown to be important for the upregulation of AP-1 activity. Furthermore, our data show that ERK and JNK activities are restored when anergy is induced in the presence of the protein synthesis inhibitor cycloheximide, or when anergic T cells are allowed to proliferate in response to exogenous IL-2. These treatments have previously been shown to prevent or reverse the anergic state. Our results suggest that defects in both JNK and ERK may result in the decreased AP-1 activity and the reduced IL-2 transcription observed in anergic T cells.
Similar articles
-
The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells.Cell Immunol. 1997 Sep 15;180(2):116-23. doi: 10.1006/cimm.1997.1182. Cell Immunol. 1997. PMID: 9341741
-
Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells.Science. 1996 Mar 1;271(5253):1272-6. doi: 10.1126/science.271.5253.1272. Science. 1996. PMID: 8638107
-
Reductions in the activation of ERK and JNK are associated with decreased IL-2 production in T cells from elderly humans stimulated by the TCR/CD3 complex and costimulatory signals.Cell Immunol. 1997 Dec 15;182(2):79-88. doi: 10.1006/cimm.1997.1226. Cell Immunol. 1997. PMID: 9514699
-
Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways.J Mol Med (Berl). 1996 Oct;74(10):589-607. doi: 10.1007/s001090050063. J Mol Med (Berl). 1996. PMID: 8912180 Review.
-
Effect of aging on T lymphocyte activation.Vaccine. 2000 Feb 25;18(16):1654-60. doi: 10.1016/s0264-410x(99)00502-2. Vaccine. 2000. PMID: 10689144 Review.
Cited by
-
Evaluation of the toxicity of iron-ion irradiation in murine bone marrow dendritic cells via increasing the expression of indoleamine 2,3-dioxygenase 1.Toxicol Res (Camb). 2017 Sep 25;6(6):958-968. doi: 10.1039/c7tx00194k. eCollection 2017 Nov 1. Toxicol Res (Camb). 2017. PMID: 30090556 Free PMC article.
-
Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.Nat Rev Immunol. 2021 Apr;21(4):257-267. doi: 10.1038/s41577-020-00454-2. Epub 2020 Oct 19. Nat Rev Immunol. 2021. PMID: 33077935 Review.
-
Exogenous avian leukosis virus-induced activation of the ERK/AP1 pathway is required for virus replication and correlates with virus-induced tumorigenesis.Sci Rep. 2016 Jan 12;6:19226. doi: 10.1038/srep19226. Sci Rep. 2016. PMID: 26754177 Free PMC article.
-
Disruption of Mekk2 in mice reveals an unexpected role for MEKK2 in modulating T-cell receptor signal transduction.Mol Cell Biol. 2002 Aug;22(16):5761-8. doi: 10.1128/MCB.22.16.5761-5768.2002. Mol Cell Biol. 2002. PMID: 12138187 Free PMC article.
-
Learning from the nexus of autoimmunity and cancer.Immunity. 2023 Feb 14;56(2):256-271. doi: 10.1016/j.immuni.2023.01.022. Immunity. 2023. PMID: 36792572 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous